EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Approach to a Child with Hypophosphatemia

Agnieszka Antonowicz, Patryk Lipiński iD, Michał Popow, Piotr Skrzypczyk iD

Biomolecules · 2025

DOI: 10.3390/biom15091321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Agnieszka Antonowicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland. Hauptthemen laut MEDLINE: Hypophosphatemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypophosphatemia is a rare ion disorder in children, but it carries the risk of serious clinical sequelae in tissues and organs with high energy requirements, such as bone tissue. This article discusses the metabolism of phosphate in the body, the clinical manifestations of hypophosphatemia, and the diagnostic tests necessary in patients with this disorder. Extra-renal causes are analyzed, and renal forms of hypophosphatemia are discussed in detail. Renal hypophosphatemia, depending on the mechanism, is divided into PTH-dependent (e.g., primary hyperparathyroidism), FGF23-dependent (e.g., X-linked hypophosphatemia), and intrinsic renal hypophosphatemia (e.g., Fanconi syndrome). The treatment of hypophosphatemia involves compensating for phosphate deficiency, often simultaneously with the supply of an active form of vitamin D. Always seek causal treatment, such as parathyroidectomy in primary hyperparathyroidism. In the FGF-23-dependent forms of X-linked hypophosphatemia and tumor-induced osteomalacia, burosumab has proven to be an effective and safe drug. Conclusions: a child with hypophosphatemia requires a multidisciplinary approach and determination of the mechanism of phosphate deficiency in the body.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypophosphatemiaHumansFibroblast Growth Factor-23ChildPhosphatesFibroblast Growth FactorsAntibodies, Monoclonal, HumanizedVitamin DParathyroid HormoneOsteomalacia

Stichwörter der Autor:innen

X-linked hypophosphatemiachildrenhypophosphatemiaphosphatericketstubulopathy

Substanzen

Fibroblast Growth Factor-23FGF23 protein, humanPhosphatesburosumabFibroblast Growth FactorsAntibodies, Monoclonal, HumanizedVitamin DParathyroid Hormone

Autor:innen und Institutionen

  • Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Institute of Clinical Sciences, Maria Skłodowska-Curie Medical Academy, 00-136 Warsaw, Poland.
  • Department of Internal Medicine and Endocrinology, Medical University of Warsaw, 02-091 Warsaw, Poland.

ORCID-Profile: Patryk Lipiński, Piotr Skrzypczyk

Zitieren

APA

Antonowicz, A., Lipiński, P., Popow, M., & Skrzypczyk, P. (2025). Approach to a Child with Hypophosphatemia. Biomolecules. https://doi.org/10.3390/biom15091321

Vancouver

Antonowicz A, Lipiński P, Popow M, Skrzypczyk P. Approach to a Child with Hypophosphatemia. Biomolecules. 2025. doi:10.3390/biom15091321

BibTeX
@article{Antonowicz2025,
  author = {Antonowicz, Agnieszka and Lipiński, Patryk and Popow, Michał and Skrzypczyk, Piotr},
  title = {Approach to a Child with Hypophosphatemia},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15091321}
}
Kostenlos starten →